ECSP034682A - Antagonistas de receptores de aminoacidos excitatorios - Google Patents

Antagonistas de receptores de aminoacidos excitatorios

Info

Publication number
ECSP034682A
ECSP034682A EC2003004682A ECSP034682A ECSP034682A EC SP034682 A ECSP034682 A EC SP034682A EC 2003004682 A EC2003004682 A EC 2003004682A EC SP034682 A ECSP034682 A EC SP034682A EC SP034682 A ECSP034682 A EC SP034682A
Authority
EC
Ecuador
Prior art keywords
ancigonists
receivers
amino acids
excitatory amino
salt
Prior art date
Application number
EC2003004682A
Other languages
English (en)
Inventor
Michael John Martinelli
Vien Van Khau
Michael Edward Letourneau
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ECSP034682A publication Critical patent/ECSP034682A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una sal farmacéutica mente aceptable de un compuesto de fórmula: (gráfico) o un pro fármaco del mismo en la que la sal farmaceúticamente aceptable se selecciona del grupo constituido por la sal del ácido D-( -)-mandélico o la sal del ácido 1, 5-naftalenodisulfónico.
EC2003004682A 2001-01-05 2003-07-03 Antagonistas de receptores de aminoacidos excitatorios ECSP034682A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26001401P 2001-01-05 2001-01-05

Publications (1)

Publication Number Publication Date
ECSP034682A true ECSP034682A (es) 2003-08-29

Family

ID=22987455

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004682A ECSP034682A (es) 2001-01-05 2003-07-03 Antagonistas de receptores de aminoacidos excitatorios

Country Status (23)

Country Link
EP (1) EP1351955A1 (es)
JP (1) JP2004520335A (es)
KR (1) KR20030066797A (es)
CN (1) CN1484642A (es)
AR (1) AR035679A1 (es)
BR (1) BR0116672A (es)
CA (1) CA2431545A1 (es)
CZ (1) CZ20031856A3 (es)
DZ (1) DZ3460A1 (es)
EA (1) EA200300770A1 (es)
EC (1) ECSP034682A (es)
HR (1) HRP20030544A2 (es)
HU (1) HUP0302528A2 (es)
IL (1) IL156138A0 (es)
MX (1) MXPA03005981A (es)
NO (1) NO20032973L (es)
NZ (1) NZ525821A (es)
PE (1) PE20020792A1 (es)
PL (1) PL361934A1 (es)
SK (1) SK8242003A3 (es)
TW (1) TW591023B (es)
WO (1) WO2002053561A1 (es)
ZA (1) ZA200304311B (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
CA2319652A1 (en) * 1998-02-06 1999-08-12 Michael Urquhart Salts of paroxetine
GB9908175D0 (en) * 1999-04-09 1999-06-02 Lilly Co Eli Method of treating neurological disorders
CN1230174C (zh) * 1999-07-06 2005-12-07 伊莱利利公司 治疗偏头痛的选择性iGluR5受体拮抗剂

Also Published As

Publication number Publication date
CN1484642A (zh) 2004-03-24
SK8242003A3 (en) 2004-01-08
EA200300770A1 (ru) 2003-10-30
BR0116672A (pt) 2003-09-23
NZ525821A (en) 2004-07-30
HRP20030544A2 (en) 2004-08-31
IL156138A0 (en) 2003-12-23
NO20032973D0 (no) 2003-06-27
NO20032973L (no) 2003-06-27
WO2002053561A1 (en) 2002-07-11
EP1351955A1 (en) 2003-10-15
AR035679A1 (es) 2004-06-23
KR20030066797A (ko) 2003-08-09
CA2431545A1 (en) 2002-07-11
TW591023B (en) 2004-06-11
ZA200304311B (en) 2004-09-02
JP2004520335A (ja) 2004-07-08
PE20020792A1 (es) 2002-09-06
MXPA03005981A (es) 2003-09-10
CZ20031856A3 (cs) 2003-09-17
DZ3460A1 (fr) 2002-07-11
HUP0302528A2 (hu) 2003-11-28
PL361934A1 (en) 2004-10-18

Similar Documents

Publication Publication Date Title
CO5271657A1 (es) Derivados de azaindol
EP1602370A3 (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
HRP20020428B1 (en) Bicyclic amino acids as pharmaceutical agents
CO5580776A2 (es) Formulacion farmaceutica estable en solucion de oxaliplatino
EA200300065A1 (ru) Окисленные сложные эфиры 4-йодфениламинобензгидроксамовых кислот
BR9900443A (pt) Esteres de ácido aril acrìlico.
BR0107837A (pt) Processo para solubilização de compostos peptìdeo 1 semelhantes a glucagon
PT1352046E (pt) Composi??es de branqueadores ?pticos, sua produ??o e sua utiliza??o
DE69507614D1 (de) 3-amino-2-oxo-piperidinessigsäurederivate, die eine argininnachahmende verbindung, mit enzyminhibitorischen wirkung enthalten
EP1392293A4 (en) METHOD FOR THE TREATMENT OF TUMORS WITH NORDIHYDROGUAIARETINIC ACID DERIVATIVES
TW200632554A (en) Photoresist composition for deep UV and process thereof
CY1120408T1 (el) Βελτιωμενες φαρμακοτεχνικες μορφες
UY27548A1 (es) Sales de ácido succínico de 5,7,14-triazatetraciclo (10.3.1.02.11.04,9) exadeca-2 (11),3,5,7,9-pentaeno y composiciones farmacéuticas
BR0002073A (pt) Processo para a preparação de um composto quiral
AU4249700A (en) Hydroxamic acid derivative
BR9913670B1 (pt) processo para a preparação de um sal de um composto de ácido carboxìlico alifático.
CO5720995A2 (es) Compuesto novedoso
IT1319234B1 (it) Processo di preparazione di gabapentina.
AR021232A1 (es) Procedimiento de preparacion de metionina.
DE69327890D1 (de) Verfahren zur Herstellung von 2-(un)substituierten 4-Alkylimidazolen
EP1306367A4 (en) SULPHONIC ACID DERIVATIVES OF HYDROXAMIC ACIDS AND THEIR USE IN MEDICAL PRODUCTS
WO2002026732A1 (en) Benzodiazepine derivative
SE9902364D0 (sv) New process
AR032043A1 (es) Un pano antimicrobiano
BR0110549A (pt) Processo para a preparação de sais de metais alcalino-terrosos do ácido d-pantotênico